This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
NetApp Gears Up to Post Q4 Earnings: What's in the Offing?
by Zacks Equity Research
NTAP's fiscal Q4 performance is likely to have benefited from strength across its all-flash storage products amid forex woes and the global Public sector downtrend.
Is Salesforce.com (CRM) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Salesforce.com (CRM) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Synopsys to Report Q2 Earnings: What's in Store for the Stock?
by Zacks Equity Research
SNPS' fiscal second-quarter performance is likely to have benefited from robust demand in the AI and high-performance computing end markets.
Buy the Spike in Intuit (INTU) Stock After Earnings?
by Shaun Pruitt
Attributed to its AI-driven solutions, Intuit exceeded expectations for its fiscal third quarter and raised its full-year revenue guidance.
Taking Stock of the Earnings Picture
by Sheraz Mian
The earnings release from Nvidia is the true highlight of this week's earnings docket, though there are a few other bellwethers on deck to report results as well. Nearing its end, how has the Q1 cycle fared so far?
Salesforce.com (CRM) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
by Zacks Equity Research
Evaluate the expected performance of Salesforce.com (CRM) for the quarter ended April 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
HPQ Gears Up to Report Q2 Earnings: What's in Store for the Stock?
by Zacks Equity Research
HP's Q2 results are likely to reflect benefits from traction in its AI-based computing and latest gaming products.
Zacks Investment Ideas feature highlights: Salesforce and Microsoft
by Zacks Equity Research
CRM eyes rebound with AI-powered Agentforce and dividends, trading 20% below highs ahead of Q1 FY26 earnings on May 28.
Semtech to Report Q1 Earnings: What's in the Cards for the Stock?
by Zacks Equity Research
SMTC's Q1 performance is likely to have benefited from strength across its infrastructure and high-end-consumer end markets.
Buy This Megacap Tech Stock Down 20% Before Earnings for AI Growth?
by Benjamin Rains
Buy Salesforce stock down 20% from its highs heading into its Q1 fiscal 2026 earnings release on May 28 for long-term AI expansion and earnings growth?
Salesforce Gears Up to Post Q1 Earnings: How to Play the Stock?
by Anirudha Bhagat
The growing adoption of generative AI-enabled solutions and continued cloud migration are likely to have aided CRM's Q1 performance.
Salesforce.com (CRM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Salesforce.com (CRM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UiPath Shares Down 37% Over a Year: Is a Turnaround in Play?
by Shuvra Shankar Dey
PATH stock has plunged significantly in a year but has rebounded sharply recently, a recovery or a trap? Here's what investors need to know.
Analog Devices Set to Report Q2 Earnings: Here's What to Expect
by Zacks Equity Research
ADI's second-quarter performance is likely to have benefited from inventory normalization, tariff reduction in China and growth across several segments.
TaskUs and Boot Barn have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
TaskUs and Boot Barn are part of the Zacks Bull and Bear of the Day article.
Intuit Gears Up to Report Q3 Earnings: Here's What You Should Know
by Zacks Equity Research
INTU shows strength, but GoCo acquisition costs may impact fiscal Q3 margins. Consider holding positions or waiting for better entry points ahead of earnings.
Autodesk Set to Report Q1 Earnings: Here's What You Should Know
by Zacks Equity Research
ADSK faces restructuring impacts. Hold the stock or wait as Q1 nears, despite margin potential. Recent growth slowdown warrants caution before increasing positions.
Salesforce.com (CRM) Stock Declines While Market Improves: Some Information for Investors
by Zacks Equity Research
Salesforce.com (CRM) closed the most recent trading day at $287.63, moving -1.21% from the previous trading session.
Workday Set to Report Q1 Results: Will Revenue Growth Boost Earnings?
by Zacks Equity Research
WDAY's first-quarter top line is likely to have gained from healthy demand across multiple end markets, product innovation and AI focus.
Why Investors Need to Take Advantage of These 2 Computer and Technology Stocks Now
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Salesforce Inc. (CRM) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Salesforce.com (CRM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Salesforce Stock Soars 13% in a Month: Time to Hold or Book Profits?
by Anirudha Bhagat
CRM's leading role in enterprise software, active AI developments, solid long-term outlook and reasonable valuation support a hold strategy for the stock.
Salesforce.com (CRM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
The latest trading day saw Salesforce.com (CRM) settling at $289.17, representing a +0.12% change from its previous close.
Salesforce.com (CRM) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
The latest trading day saw Salesforce.com (CRM) settling at $278.23, representing a +1.78% change from its previous close.
Investors Heavily Search Salesforce Inc. (CRM): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Salesforce.com (CRM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.